Skip to main content
. 2023 Jun 29;32(18):2822–2831. doi: 10.1093/hmg/ddad109

Table 1.

Summary of clinical features

Individual F1 F2.1 F2.2 F3
Amino acid change (NM_031934.6) p.(Arg211His) p.(Gly202Val) p.(Gly202Val) p.(Glu218Lys)
Inheritance Homozygous Homozygous Homozygous Homozygous
Gender Male Male Male Male
Country of origin Morocco Czech Republic Czech Republic Morocco
Consanguineous Yes No No Yes
Age at last examination 22 + 1 WG 13 + 5 WG 21 + 6 WG 3 months
Prenatal ultrasound signs Oral cleft, Hand-foot polydactyly, Abnormal cardiac morphology, Short fetal femur length, Renal hypertrophy Multiple developmental defects Multiple developmental defects Bilateral cleft lip, Hand-foot polydactyly, Atrioventricular canal defect, Corpus callosum agenesis, Polyhydramnios
Neonatal issues NA NA NA Respiratory distress
Cranio-facial defects Hypertelorism, Microtia Micrognathia, Turricephaly Hypertelorism, Synophris Micrognathia, Low-set ears Macrocephaly, Broad forehead, Wide nasal bridge, Retrognathia
Oral anomalies Bilateral oral cleft, Short lingual frenulum Bilateral oral cleft Bilateral oral cleft Bilateral oral cleft, Lobulated tongue
Hand anomalies Bilateral polysyndactyly Prexial and central polydactyly (heptadactyly) Preaxial and central polydactyly (heptadactyly) Bilateral polysyndactyly
Foot anomalies Bilateral polysyndactyly, Deviation of the hallux Prexial and central polydactyly (heptadactyly) Preaxial and central polydactyly (left hexadactyly, right ectrodactyly), Deviation of the right hallux Bilateral polysyndactyly
Structural cerebral anomalies Corpus callosum agenesis, Cerebellar hypoplasia NA NA Corpus callosum agenesis
Cardiac anomalies Ventricular septal defect, Left ventricular hypoplasia No Hypoplastic left heart, Persistent truncus arteriosus Atrioventricular canal defect
Other clinical features Anal atresia, Short femur Small anus Anal atresia, Short femur and humerus, Bilobar right lung Anorectal anomaly, Possible Hirschsprung Dyspnea, Pneumopathy

Overview of clinical features observed in individuals with pathogenic RAB34 variants. NA, not available.